Articles

Poll

Podcasts

Slideshows

Videos

Psychiatry

Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.

A study found long-acting injectables reduced mean Young Mania Rating Scales scores in adolescents with bipolar mania from 33.8 at baseline to 21.7 at month 1.

Long-Acting Injectables Effectively Manage Bipolar Mania in Adolescents

Uric acid levels, commonly used to indicate gout, are closely associated with bipolar-affected mania.

Serum Uric Acid May Be Biomarker for Bipolar Affective Disorder

Unlike approved antidepressant drugs which have warnings on their labels stating they may increase the suicide risk, NRX-101 demonstrates meaningful reductions in suicidality.

NRX-101: First Antidepressant to Lower Suicidality in Bipolar Depression

Four-year, phase 3 data from APA 2024 show olanzapine/samidorphan provided consistent antipsychotic efficacy and weight-related safety in patients with either schizophrenia or bipolar I disorder. 

Olanzapine/Samidorphan Maintains Mood Disorder Efficacy, Weight and Glycemic Tolerability at 4 Years

The FDA approved iloperidone for acute treatment of bipolar I disorder on April 02, 2024, according to Vanda Pharmaceuticals.

FDA Approves Iloperidone (Fanapt) for Acute Treatment of Bipolar I Disorder

In an interview with HCPLive, Leesha Ellis-Cox, MD, MPH, broke down factors contributing to the bipolar disorder diagnosis gap for African Americans.

Leesha Ellis-Cox, MD, MPH: Steps to Closing the Bipolar Disorder Diagnosis Gap for Black Adults

In an interview, Jacob Ballon, MD, MPH, discusses the significance of his team’s study which found olanzapine and samidorphan was well-tolerable for up to 4 years of treatment for schizophrenia and bipolar disorder treatment.

Jacob Ballon, MD, MPH: Discusses Takeaways from Studying Long-Term Olanzapine and Samidorphan

A study demonstrated olanzapine and samidorphan’s (LYBALVI) safety, tolerability, and durability during a 4-yeat treatment period.

Olanzapine, Samidorphan Effective for Long-Term Schizophrenia, Bipolar Disorder Treatment 

Mothers with mood disorders—either bipolar disorder, major depressive disorder— or schizophrenia/ schizoaffective disorder are not associated with their offspring’s risk for type 1 diabetes. Results suggest mothers with bipolar disorder tend to develop type 1 diabetes, but data is not clinically significant.

Mothers’ Mental Disorders Is Not Linked to Type 1 Diabetes in Offspring

A large systematic review assessing more than 60 drugs for bipolar depression shows only a handful were statistically signifcantly better than placebo per depressive symptom outcomes.

7 Pharmacological Agents That Benefit Acute Bipolar Depression

The HCPLive bipolar disorder page is a resource for medical news and expert insights on BPD. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for bipolar disease, and more.